the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
November 12, 2024 – The duration of human life (longevity) is influenced by genetics, the environment, and lifestyle. Environmental improvements beginning in the 1900s extended the average life span dramatically with significant improvements in the availability of food and clean …
November 02, 2024 – In the popular press and with people of public interest and fame in the weightloss and beauty industries, Semaglutide has been considered the slimming miracle elixir par excellence. Wegovy, Rybelsus, and Ozempic, all of which are based on …
Semagludite: The cause for NAION and Blood Clots? Read more »
October 31, 2024 – Severe obesity is already a major problem for many children – all the more so because obese children very often become obese adults. There are currently no obesity medications for six to twelve year olds. Could …
Does the weight loss injection liraglutide also work in children? Read more »
26 May 2024 – Semaglutide is the active ingredient in the three Novo Nordisk drugs Ozempic, Rybelsus, and Wegovy that are being used for weight loss purposes. Thus, Ozempic, which was approved in 2017 by the FDA as a Type 2 diabetes treatment, …
Severe Stomach Conditions in Patients taking Semaglutide Read more »
May 06, 2024 – Non-Hispanic persons of African ancestry typically have worse clinical outcomes from colorectal cancer (CRC) than individuals of other heritages, a disparity attributed to many factors, including socioeconomic, environmental, and genetic influences, as well as less access …
April 14, 2024 – There have recently been several media publications along the lines like “Mom with ‘one-of-a-kind’ disease that causes tumors to grow over whole body terrified of dying alone” referring to a female patients out from the Jamaicas suffering …
Neurofibromatosis (NF-1): Terrifying tumour growth over the whole body Read more »
March 27, 2024 – Lyrica (Pregabalin) is a drug from the group of gabapentinoids and is an anticonvulsant active ingredient. It has been approved throughout the EU since 2004 for the treatment of neuropathic pain, epilepsy and generalized anxiety disorder. …
March 15, 2024 – On the occasion of International Rare Disease Day on February 28, the Swiss Foundation for People with Rare Diseases drew attention to the current challenges and needs of those affected. In Europe, a disease is considered …
Rare diseases: No diagnosis or the most expensive drug in the world? Read more »
March 04, 2024 – People have been looking for ways to get rid of multi-resistant germs for many years. US researchers at Harvard University have developed a new antibiotic that is effective against a variety of resistant bacteria. The results …
Multi-resistant bacteria: New antibiotic destroys hospital germs Read more »
February 10, 2024 – Noma is a disease that many people prefer to ignore. The sight of the affected small children is unbearable. There are open wounds on the face. Entire cheek areas appear as if eaten away. Children who …